This article is more than 5 years old. Information may no longer be current.

IOPtima launches Lipitear phospholipid microemulsion

Issue: October 2017

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

IOPtima launched Lipitear, a phospholipid-based microemulsion formed by an aqueous phase and a lipidic phase that helps restore the microenvironment of the ocular surface, the company announced in a press release.

Lipitear also enhances the physiological process of corneal re-epithelization after ocular surgery and reduces the symptoms and signs of ocular surface disorder.

It restores the natural tear film, exhibiting a long-lasting effect on a dry eye by preventing evaporation and lubricating the corneal surface, the release said.

The device is currently marketed in Europe under a CE mark but has not yet been registered in the United States.